PepGen Inc (PEPG) Quick Liquidity

Symbol and logo of brand PepGen Inc. (PEPG)

The price trend for PepGen Inc. (PEPG) reflects a value of 13.32. The business focuses on developing therapies for muscle pathologies, where research and development costs keep operating efficiency in negative territory. The team consists of top geneticists attracted by innovative projects and stock option programs. High salaries and academic freedom help the company retain first-class biochemists developing neuromuscular treatments.

PepGen (PEPG) - Immediate Liquidity from 04/28/2023 to 10/29/2026

Metric breakdowns and analytics for PepGen Inc. (PEPG)

- market value and analyst target forecast:
Price Chart pepgen.com|PEPG - Average Forecast Price
- market capitalization details:
Market Value PepGen Corp|PEPG - Full Business Value
- book capitalization data:
Book Value per Share PepGen|PEPG - Total Stockholders' Equity|Market Value to Book Value Ratio pepgen.com|PEPG - Total Asset Value of Company
- debt obligations and liquidity statistics:
Total Debt to Capital PepGen Inc.|PEPG - Long-Term Indebtedness to Equity|Short-Term Debt to Capital pepgen.com|PEPG - Company Cumulative Debt|Debt to Book Capitalization Ratio PepGen Corp|PEPG - Company Long-Term Indebtedness|Company Current Liabilities PepGen|Quick Ratio pepgen.com
- earnings and valuation multiples indicators:
PEPG - Net Financial Result
Comprehensive company analysis:PepGen Inc.
Flagship merchandise of PepGen Inc.

This indicator reflects operational resilience by measuring the company's ability to cover short-term liabilities using cash and accounts receivable, excluding low-liquidity inventories. For PepGen Inc. (PEPG), which focuses on costly clinical trials for neuromuscular pathology drugs, this metric is critical for assessing financial autonomy, clearly demonstrating the quick liquidity trend.

Key competitors

Biogen Corp (BIIB) - Quick Liquidity|Immediate Liquidity Neurocrine Corp (NBIX)|Quick Liquidity Regencell Bioscience|axsome.com - Critical Liquidity Ratio|Quick Ratio ACAD|XENE - Immediate Liquidity|Quick Liquidity Viking Pharma VKTX|SUPN (Supernus Corp) - Critical Liquidity Ratio|Catalyst Pharmaceuticals - Quick Ratio|Critical Liquidity denalitherapeutics.com (DNLI)|HRMY: Quick Ratio|Immediate Liquidity Biohaven Ltd (BHVN)|Quick Liquidity Amylyx|Immediate Liquidity Ratio TRVI (Trevi Corp)|Quick Liquidity Indicator PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Intermediate Coverage Ratio|Quick Ratio CBLL (CeriBell)|Interim Coverage Ratio Prothena Corp (PRTA)|ALEC - Quick Liquidity|ANNX (Annexon Biosciences Inc.) - Immediate Liquidity Ratio|OMER: Quick Ratio|Quick Liquidity Indicator neurogene.com|Quick Liquidity Indicator ACIU|Voyager Therapeutics Inc (VYGR) - Interim Coverage Ratio|Quick Liquidity Neumora Therapeutics Inc (NMRA)|SCLX: Critical Liquidity Ratio|Quick Ratio TVGN (Tevogen Bio Holdings)|Alpha Cognition Inc (ACOG) - Immediate Liquidity|CGTX - Quick Liquidity|Critical Liquidity Ratio IKT|SAVA: Quick Ratio|Critical Liquidity Assertio ASRT|Quick Liquidity Coya Therapeutics Inc|Immediate Liquidity Ratio VTGN (VistaGen Therapeutics Inc)|Quick Ratio OVID|ABOS - Immediate Liquidity|CervoMed Inc - Quick Liquidity Indicator|Quick Ratio Alterity Therapeutics Ltd. ATHE|CLNN - Quick Liquidity|Intermediate Coverage Ratio JUNS (Jupiter Neurosciences, Inc.)|Relmada Therapeutics, Inc. (RLMD) - Quick Liquidity|Immediate Liquidity Annovis Bio Inc (ANVS)|Quick Liquidity Grace Therapeutics Inc|Firefly Neuro - Critical Liquidity Ratio|Quick Ratio KLTO|NRSN - Immediate Liquidity|Quick Liquidity Reviva Pharmaceuticals Holdings, Inc. RVPH|MTVA (MetaVia Inc.) - Critical Liquidity Ratio|NeurAxis, Inc - Quick Ratio|Critical Liquidity Helius Medical (HSDT)|PASG: Quick Ratio|Immediate Liquidity Neuphoria Therapeutics (NEUP)|Quick Liquidity Minerva Neurosciences, Inc.|Immediate Liquidity Ratio ATHA (Athira Pharma Inc)|Quick Liquidity Indicator ADXN (Addex Therapeutics, Ltd.)|ALZN (alzamend.com) - Intermediate Coverage Ratio|Quick Ratio CYCN (Cyclerion Therapeutics, Inc.)|Interim Coverage Ratio Protagenic Therapeutics Inc. (PTIX)|KTTA - Quick Liquidity|CRGT (Cortigent, Inc.) - Immediate Liquidity Ratio|ATXI: Quick Ratio|Quick Liquidity Indicator BrainStorm Cell Therapeutics Inc.|Quick Liquidity Indicator CARA|chromocell.com (CHRO) - Interim Coverage Ratio|Quick Liquidity Eliem Therapeutics (ELYM)|ITCI: Critical Liquidity Ratio|Quick Ratio LBPH (Longboard Pharma)|Marinus Pharma (MRNS) - Immediate Liquidity|NKGN - Quick Liquidity|Critical Liquidity Ratio NRBO|SAGE: Quick Ratio|Critical Liquidity Synaptogenix Inc. SNPX|Quick Liquidity Trevena, Inc|Immediate Liquidity Ratio VIGL (Vigil Neuro)|Quick Ratio WENA|CERE - Immediate Liquidity